Expression of the cx43 gene for the gap junction protein, connexin43 (Cx43), through activator protein (AP)-1 activity has been shown to be inhibited in human primary myometrial cultures pretreated with estrogen. In the present study, the primary myometrial cultures were shown to express predominantly ERb, a subtype of estrogen receptor that inhibits AP-1 activity when bound to agonists. ERb levels were decreased in the primary myometrial cultures after treatment with the phorbol ester, 12-O-tetradecanolyl-13 acetate, to stimulate AP-1 activity, and this effect is inhibited if cells were pretreated with estrogen.
Introduction
Escalation of serum concentrations of steroid hormones, estrogens (17b-estradiol, estrone, and estriol), in women during gestation suggest that these hormones play an essential role during pregnancy in humans (1) . Estrogens are found to be stimulatory to the initiation of labor in animals that experience progesterone withdrawal before parturition (2) (3) (4) . In contrast, in animals such as guinea pigs, which do not have pre-parturition progesterone withdrawal, estrogen is inhibitory to the initiation of labor (4) . The role of estrogen has not been determined in humans, who also do not experience pre-parturition progesterone withdrawal. One of the tissues targeted by estrogen during gestation is the uterine smooth muscle, the myometrium (5) . Labor initiates as the myometrium ceases being quiescent and displays synchronous contractility. These physiological changes are believed to result from changes in myometrial gene expression.
Estrogen regulates gene expression in estrogentargeted tissue through binding one of two members of the superfamily of steroid hormone nuclear receptors, the estrogen receptors (ER) (6) . The two subtypes of estrogen receptors, ERa (67 kDa) and ERb (60 kDa) are coded by separate genes (7, 8) . They are expressed alone or together in several different tissues of the body (8, 9) . ERa and ERb have been demonstrated to have the same pharmacological responses through the estrogen response elements (EREs) in DNA promoters (10, 11) . Estrogen receptors also modulate the expression and activity of transcription factors such as the protooncogene products, c-Jun and c-Fos (12) (13) (14) . Jun and Fos family members regulate the expression of specific genes by binding to DNA elements known as activator protein (AP)-1 sites (15, 16) . In contrast to the classical receptor-mediated transactivation from EREs, ERa and ERb have opposite regulatory activity when mediated through the AP-1 promoter element (17) : agonist-bound ERa aactivates AP-1 activity, whereas agonist-bound ERb inhibits AP-1 activity. However, when bound by antagonists, both estrogen receptors activate transcription from AP-1 sites. The transactivation of ER through AP-1 activity involves its interaction with Jun and Fos family members, and the outcome is sensitive to the member of the Jun/Fos family that is expressed (18) .
cx43, the gene for the gap junction protein, connexin43 (Cx43), is a labor-associated gene that becomes highly expressed in the myometrium before the onset of parturition (5, 19, 20) . Early expression of cx43 is associated with premature labor (20) . Cx43 gap junctions assemble and promote intercellular communication, which is believed to synchronize labor contractions through the passage of molecules such as Ca 2+ (5, 20) . Regulation of cx43 expression probably reflects the regulation of other labor-associated genes in the myometrium, as AP-1 is a ubiquitous regulatory element.
We have determined that the 5 0 flanking promoter region of the human cx43 gene contains an AP-1 site (21), the activity of which may be important for the induction of cx43 expression at term (22) . We have shown that increased cx43 expression in human myometrium at term correlates with increased expression of c-Jun and c-Fos (22) , and have demonstrated that stimulation of human myometrial AP-1 activity transiently increases c-jun and c-fos expression and induces cx43 gene transcription (22) . This is true whether AP-1 activity is stimulated through protein kinase C activation after treatment with 12-O-tetradecanolyl-13-acetate (TPA) or through protein kinase A activation after incubation with 8-bromo-cAMP (21, and T Peresleni, J J Wu & J Andersen, unpublished observations). We have shown that estrogen antagonizes the induction of cx43 expression through AP-1 activity in primary myometrial cultures without significantly decreasing c-Jun or c-Fos levels (22) . These published results suggested that the cultured uterine cells might express ERb.
We previously analyzed the levels of ERa in term myometrium and determined that the levels of this receptor protein were negligible in pregnancy myometrium (22) . With the availability of antibodies to ERb, in the present study we analyzed the expression of ERb in primary cultures of human myometrial cells and in term myometrial tissue. We found an inverse relationship between the levels of expressions of ERb and cx43 in the term human myometrial tissue tested. 
Materials and methods

Tissue acquisition
Cell culture system
For cell culture experiments, myometrial tissue was processed and cultured as described by Zhao et al. (24) and Andersen et al. (25) . The cultures were not passaged and were used within 2 weeks of the initial plating. Twenty-four hours before the experiments, the culture medium was changed to serum-free, phenol-red-free Dulbecco's modified Eagle's medium supplemented as described elsewhere (25, 26) . All experiments with the primary cultures were performed using this defined serum-free medium. Ethynyl estradiol was added to the cultures in a concentration of 10 nmol/l for 48 h. TPA (CalBiochem-Novabiochem Corporation, La Jolla, CA, USA) was added to the cultures in a concentration of 100 ng/ml for 3 h. Control samples were treated with vehicles, 0.1% ethanol and 0.03% dimethyl sulfoxide.
Immunoblot analysis
The relative levels of ERa (67 kDa), ERb (60 kDa) and Cx43 (43 kDa) proteins were determined for 100 mg of each of the tissue lysates through immunoblot analysis. Polyclonal antibodies (pAb) for ERa (rabbit polyclonal SC 543) and ERb (goat polyclonal SC 6822) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Antibody for Cx43 (mouse monoclonal mAb 3068) was purchased from Chemicon Internationals, Inc. (Temecula, CA, USA). Preparation of cell lysates and immunoblot analysis using enhanced chemiluminescence (Amersham Life Science, Bucks, UK) were performed as previously described (24, 25) . Prestained marker proteins (BioRad) were run in parallel. Cell lysates from HeLa cells (ATCC CCL 2), MCF7 breast cancer cell line (ATCC HTB 22) and the human metastatic prostate cell line, LNCaP.FGC (ATCC CRL 1740) were used as controls in the immunoblot analyses.
Immunohistochemical detection of ERb
Immunohistochemical detection of ERb in frozen myometrial tissue was performed as previously described (22) using the same anti-ERb pAb that was used for immunoblot analysis. A section of frozen prostate tissue from a 66-year-old man with prostatic adenocarcinoma was also analyzed as a positive control for ERb. Incubations with primary antibodies were performed overnight at 4 ЊC. Sections were also counterstained with light green, using standard protocols. Duplicate sections were stained with hematoxylin and eosin using standard procedures to facilitate identification of cellular elements and areas of necrosis (data not shown). Peroxidase activity was observed by light microscopy using a 25 × objective and photographed using a Princeton Instruments Micromax cooled CCD digital camera. Evaluation of myometrial results was determined by comparison of staining in tissue sections that were incubated with anti-ERb pAb with duplicate tissue sections that were incubated without primary antibody.
RT-PCR analysis
The relative levels of ERb mRNA were analyzed in myometrial tissue using RT-PCR analysis. Total RNA was isolated from tissue as described elsewhere (24) . Then 80 mg total RNA were reverse-transcribed with dT primers for 1 h at 37 ЊC, following standard procedures. cDNA was purified using phenol-chloroform extraction and precipitated with ethanol. PCR was performed to amplify the cDNA resulting from reverse-transcription of 1, 2 or 5 mg total RNA. PCR conditions were as described by Vladusic et al. (27) . PCR products for b-actin and b2 microglobulin were generated to assess cDNA quality. PCR reactions using ERa and ERb primers (27) resulted in 417 base pair and 435 base pair products, respectively. PCR products were analyzed by electrophoresis on 3% NuSieve agarose, 1% agarose gel containing ethidium bromide and compared with lowmolecular-weight DNA marker, which was generated by digesting pBR322 with HaeIII. PCR products from plasmids carrying either ERa cDNA or ERb cDNA were used as positive controls.
Results
ERb expression in human myometrial tissue at term
The relative levels of ERa and ERb were determined by immunoblot in lysates from 10 cesarean section (c-section) myometrial tissue samples and one postpartum myometrial tissue (Table 1 ) (22) and compared with the relative levels in non-pregnancy myometrial and leiomyoma tissue lysates from cycling women (Fig. 1) . In addition, lysate from MCF7 breast cancer cells was analyzed as a positive control for ERa; lysate from HeLa cells was analyzed as a negative control for ERa and ERb. Also, because ERb is expressed in prostate tissue (8, 10) , lysate from the human metastatic prostate cell line, LNCaP.FGC, was analyzed. Table 1 ). For each tissue, 100 mg protein lysate was loaded. Lanes: Mf, non-pregnancy myometrial tissue derived from a woman in the follicular phase; Lf, leiomyoma tissue from the same woman as Mf; Ml, non-pregnancy myometrial tissue derived from a woman in the luteal phase; Ll, leiomyoma tissue from the same woman as Ml; H, HeLa cell lysate; P, prostate cell line LNCaP.FGC (control); B, lysate from the breast cancer cell line MCF-7; Pp, postpartum myometrial tissue lysate; m, lysate from primary myometrial cultured cells derived from luteal-phase tissue. Lanes CS 6, 10, 4 and 7 each contain term myometrial lysate from c-section tissue samples. The CS numbers correspond with those in Table 1 . Patient 10 was not in labor, patients 4 and 6 were in pre-active labor and patient 7 was in active labor at the time of c-section. Dashes mark the two ERb isoforms detected in myometrial cultured cells.
However, the prostate cell line was negative for both subtypes of ER.
As observed previously, ERb protein was barely detectable in the term myometrial tissue by immunoblot. In contrast to ERa (Fig. 1, top panel) , ERb was detected at levels significantly greater (2.5-13 times) than those in the non-pregnancy tissue (Fig. 1, 
Two protein bands were observed for ERb in the immunoblot. Both of these bands are easily seen in Fig. 1 in the lane containing lysate from cultured myometrial cells (lower panel, lane m), as indicated by dashes). The faster moving form of ERb was the predominant form observed in the analysis of cultured leiomyoma cell lysate (data not shown). The reason for the difference in mobility between the two ERb isoforms has not been examined.
Localization of ERb to the nucleus in term myometrial tissue
Immunohistochemistry was used to detect ERb protein in the same tissue as was analyzed by immunoblot ( Table 1 ). The same anti-ERb pAb was used in both the immunoblot and immunohistochemistry analyses. Table 1 for profiles of the pregnant patients.
and CS 6 and with Fig. 2 panels A and C, respectively). Nuclear staining was also observed for prostate tissue from a 66-year-old man diagnosed with prostatic adenocarcinoma (Fig. 2, panel E) . This is in contrast to that observed in the prostate cell line (Fig. 1, lane P) . No nuclear staining was observed for non-pregnancy myometrial tissue (Fig. 2, panel B) or for the term tissue (CS 7) taken from a woman in active labor (Fig. 2, panel  B) . These results confirmed those obtained by immunoblot and indicated that ERb is found in the nucleus of cells in myometrial tissue with a relatively high degree of expression. In contrast, in tissue with relatively low ERb expression, no nuclear staining was observed (Fig. 2, panels B and D) .
Relationship between ERb and cx43 expressions in human myometrium at term
Immunoblot analysis was used to measure the relative levels of ERb (Fig. 3A) in term myometrial tissue samples that had previously been used to analyze levels of Cx43 and ERa (22) . Lysates from HeLa cells, MCF7 breast cancer cells and non-pregnancy myometrial tissue were also analyzed (Fig. 3, lanes marked H, B and m, respectively). The numbers at the top of each CS lane in Fig. 3 designate the c-section sample number listed in Table 1 , samples (Fig. 3A, CS lanes 3,   8, 1, 9 , 2, 6, [10], 4, 5, 7) having been placed in order of increasing expression of cx43 (compare with Fig. 3B ; technical difficulties occurred with application of sample 10). The samples that had the greatest levels of Cx43 protein also had significantly greater levels of c-Jun and c-Fos (22) . It is evident that ERb levels decreased in the c-section samples as Cx43 levels increased. In addition, ERb levels were increased in the postpartum myometrial tissue (Fig. 3, Pp) , and these tissue samples had reduced Cx43 protein levels compared with those observed in the c-section tissue (Fig. 3 , lanes CS). It is interesting that, in general, the slowermoving form of ERb was found in tissue from women in pre-active labor or in postpartum tissue samples (Fig. 3A , compare mobility of ERb in samples CS 8, 1, 9, 2 [and 10 in Fig. 1 ] with mobility in samples CS 6, 4 and Pp).
Effect of treatment with estrogen or TPA on ratios of ERa and ERb in cultured myometrial cells
We observed previously that treatment with estrogen antagonized TPA induction of cx43 expression in the uterine cells (22) . In the present study, we analyzed by immunoblot the relative levels of ERa and ERb in cultured luteal-derived myometrial cells after treatment with estrogen, TPA, or both. Untreated myometrial cells expressed both ERa and ERb (Fig. 4A, lane 0) . Treatment with TPA (100 ng/ml) (Fig. 4A , lane TPA) resulted in the down-regulation of the expression of both receptors. Treatment with 10 nmol/l ethynyl estradiol for 48 h (Fig. 4A , lane E) resulted in upregulation of ERb expression. However, in cells pretreated with the estrogen and then treated with TPA, ERa expression was downregulated and ERb was upregulated (lane marked TPA/E). Pretreatment with estrogen altered the ratio of ERb to ERa in cells treated with TPA compared with that found in cells treated with TPA alone (compare ERa and ERb in lanes marked TPA and TPA/E).
For comparison, levels of Cx43 were examined in the same cells as shown in Fig. 4A . Treatment with estrogen alone caused upregulation of cx43 expression through an unknown mechanism. Treatment with TPA alone upregulated the expression of cx43 and resulted in a greater ERa : ERb ratio. Treatment with TPA in cells exposed to estrogen downregulated cx43 expression and resulted in a lower ERa : ERb ratio. As ligand-bound ERb antagonizes AP-1 activity, the downregulation of ERa and upregulation of ERb in the myometrial cells may account for the antagonism by estrogen of TPA induction of cx43 gene expression.
Discussion
Uterine smooth muscle is the primary tissue involved in labor. At term, the myometrium changes from a quiescent to a dynamic muscle, which produces rhythmic contractions to expel the fetus from the mother. Regulation of parturition is linked to regulation of myometrial activity. In turn, increased myometrial activity is ancillary to changes in the regulation of gene expression at term. High levels of estrogen in the serum of pregnant women suggest that estrogen may have an essential role in regulating myometrial gene expression during pregnancy.
In our previous work (21, 22) , we examined the levels of ERa in term myometrial samples and were surprised to find very low levels at term. In the present study, we found that ERb, the newly found estrogen receptor subtype, was expressed in relatively high levels in the myometrium from women undergoing elective and indicated c-section, compared with that in myometrial and uterine leiomyoma tissues from non-pregnant women. Our results indicate that, whereas ERa is the predominant estrogen receptor subtype in nonpregnancy myometrium, ERb is the predominant estrogen receptor subtype in term myometrium.
Pedeutour et al. (28) recently reported detecting ERb expression in human non-pregnancy myometrium and uterine leiomyoma tissues using RT-PCR. Our detection of ERb mRNA in non-pregnancy tissue using the RT-PCR method is in agreement with our detection of the relative levels of ERb protein by immunoblot. We conclude from the results of both techniques that ERb expression is very low in the non-pregnancy myometrium and leiomyoma tissues, compared with term myometrium.
Expression of ERb in leiomyoma tissue suggests that leiomyoma pathobiology may play a greater part than does a heightened response to estrogen. We have previously reported that ERa has increased expression in leiomyoma tissue compared with myometrial tissue, particularly during the follicular phase (26) . In contrast, ERb levels in both myometrial and leiomyoma tissues vary similarly during the menstrual cycle, being lowest at mid cycle. The major characterized difference between the two subtypes of ER involves their transactivation functions in the context of AP-1 elements and in the ability of different ligands to affect this function (10, 11, 17) . Gene expression in the tumor may be affected adversely by an inappropriate ratio of the two estrogen receptors at the beginning of the menstrual cycle, when ERa levels are abnormally increased. AP-1 activity, for example, may not be under normal control as a result of the altered ERa : ERb ratio. This is significant, as AP-1 activity is a primary pathway used to control cell growth (15, 16) .
Our recent studies clearly demonstrate that increased AP-1 activity is involved in the induction of cx43 expression in term myometrium (21, 22) . Myometrial AP-1 activity involves activation of c-Jun and c-Fos proteins, the factors that bind to AP-1 sites in DNA. A proximal AP-1 site in the human cx43 promoter functions to induce cx43 transcription in primary cultures of uterine smooth muscle cells after activation of AP-1. Our work points to the possibility that increased AP-1 activity may also have a role in the induction of the other labor-associated genes.
The involvement of the AP-1 activity in the induction of cx43 expression in human myometrium at term suggests that, during pregnancy, estrogen may downregulate cx43 expression by controlling the activities of c-Jun and c-Fos proteins through interaction with ERb. One possibility is that ERb interacts with the AP-1 binding proteins and interferes with their transactivation functions, thus keeping the induction of cx43 expression in check. The cx43 gene is then one of the first genes to be identified that may have this regulation. In support of this, there appears to be an inverse relationship between the expression of ERb and the expression of cx43 in term myometrium. It appears that, as ERb expression decreases, cx43 gene expression increases. Loss of ERb expression or function appears to tip the scales in favor of cx43 expression.
In cultured myometrial primary cells, two forms of ERb protein separated after gel electrophoresis. The reason for the change in protein mobility is unknown. Shifts in protein mobility may occur because of differential mRNA splicing or post-translational protein modifications such as phosphorylation (29) . A posttranslational modification of a protein may enhance or decrease its activity, or may alter the half-life of the protein (30) . A shift in protein mobility to the slower form of ERb correlated with increased cx43 expression and a decrease in ERb levels. The reason for the change in ERb mobility may reveal a regulatory mechanism for ERb that is important to its function. The mobility of ERb in term myometrial tissue changed according to labor status. Regulation of ERb protein may be part of the switch that allows for changes in myometrial gene expression at term. Downregulation of ERb function or levels would lift the inhibition of AP-1 activity and allow for subsequent induction of labor-associated genes that are regulated through AP-1. It is important to characterize the modification and decipher its role in the function of ERb in regulating gene expression.
Although cultured myometrial cells are derived from the tissue of non-pregnant women, they have a number of the morphological and physiological characteristics of term myometrium. For example, Cx43 protein was not detectable in normal non-pregnancy myometrial tissue by immunohistochemistry or by immunoblot, but, when cultured, the myometrial cells derived from non-pregnancy tissue expressed high levels of Cx43 protein (compare references 22 and 25). The primary myometrial cells have high expression of other laborassociated genes such as thrombospondin-1 (31) . Like term myometrium, and unlike non-pregnancy myometrium, cultured myometrial cells derived from nonpregnancy tissue express ERb. They also express relatively high levels of functional progesterone receptor, in common with term tissue (22, 24) . Primary myometrial cells from non-pregnancy tissue contain oxytocin receptors and respond to oxytocin with transient calcium oscillations that are not distinguishable from those from myometrial cells derived from pregnancy tissue (32) . The reason that the cultured myometrial cells were so similar to pregnancy myometrium may be due to the use of fetal bovine serum or the thinning out and stretching of the attached explant pieces during culturing. Nonetheless, their similarity with pregnancy myometrium makes them a useful in vitro system for studying the myometrial-specific regulation of human genes such as cx43 and ERb.
Previously, we had screened for expression of an alternative estrogen receptor in term myometrium by binding fluorescein-conjugated estradiol to the tissue. Negative results using this technique made us conclude at that time that an alternative estrogen receptor was not expressed at high levels. Interestingly, Pulkkinen & Hämäläinen (33) and Perrot-Applanat et al. (34) also found low estrogen binding in human term myometrium. In contrast, using specific antibodies to ERb, we found that expression of the newly found ERb was increased in term myometrial tissue. It may be that endogenous estrogen bound to ER in situ created an artifact in the first study by blocking the binding of the fluorescein-conjugated estradiol. This appears to be an intrinsic weakness of the method.
Our new results are significant for two reasons. Firstly, finding relatively high levels of ERb in term myometrium supports the concept that estrogen plays a significant role in regulating myometrial gene expression at least during the last trimester. Secondly, the observation that expression of ERb was inverse to that of cx43, one of the labor-associated genes, suggests that ERb may play an important biological role during late pregnancy in downregulating expression of laborassociated genes in uterine smooth muscle cells. Our study supports the concept that estrogen, like progesterone, plays an essential role in pregnancy maintenance in humans. It would be interesting to see if ERb is also expressed in the term myometrial tissue of animals such as guinea pigs, which do not have progesterone withdrawal before parturition. Perhaps these animals would be betters models for human parturition than sheep or rats (4).
